Glooko, Eli Lilly to collaborate on connected insulin pens
By HME News Staff
Updated 8:02 AM CDT, Fri May 7, 2021
GOTHENBURG, Sweden – Glooko will partner with Eli Lilly for a strategic digital health collaboration using Eli Lilly’s connected insulin pens, the Tempo Pen and Tempo Smart Button. Through the agreement, the Tempo Smart Button will pair with Glooko’s software to integrate personalized health care data from the Tempo Pen, allowing it to be viewed and analyzed alongside other relevant data from other devices, fitness trackers and food logs. “Lilly is a valued partner for Glooko, and we are pleased to collaborate with them on this important digital health launch,” said Russ Johannesson, CEO of Glooko. “Studies have shown that when smart insulin devices are synced with digital health tools, it improves outcomes for people living with diabetes. We are excited about continuing to expand the availability of our solution and look forward to helping more people manage their diabetes through our innovative products.”
Comments